Search research articles
Contact Us
Filters
Showing results (11-20 of 334) with videos related to
Page
of 34
Sort By:
European Urology Oncology
|
April 25, 2019
Re: Ricardo G. Alvim, François Audenet, Emily A. Vertosick, Daniel D. Sjoberg, Karim A. Touijer. Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL, and PADUA Systems. Eur Urol Oncol 2018;1:428-34: Nephrometry Score: Quantifying the Complexity of the Tumor or Struggling with the Complexity of the Score?
Fabio Muttin, Umberto Capitanio, Francesco Montorsi, et al.
European Urology Open Science
|
January 6, 2022
Cytoreductive Nephrectomy in 2021: Obsolete but Necessary
Umberto Capitanio, Andrea Necchi, Francesco Montorsi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2016
The Authors Respond
Nicola Fossati, Alessandro Larcher, Alberto Briganti, et al.
European Urology
|
March 30, 2016
Oncologic Surveillance for Renal Cell Carcinoma: What Is Still Needed?
Umberto Capitanio, Giorgio Gandaglia, Alessandro Larcher, et al.
The Journal of Urology
|
May 13, 2026
Interpreting Matched Analyses of Partial Versus Radical Nephrectomy for cT2 Tumors: Methodological Caveats and Clinical Implications
Umberto Capitanio, Francesco Cei, Alessandro Larcher, et al.
Urologic Oncology
|
June 1, 2022
Reply to Sebastiano Buti and Giulia Claire Giudice's Letter to the Editor comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: Is AUC close enough to clinical practice? Urol Oncol. 2022 Apr 14:S1078-1439(22)00066-7. doi: 10.1016/j.urolonc.2022.02.015
Giuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
February 10, 2018
You Can Trust a Crystal Ball About as Far as You Can Throw It
Umberto Capitanio, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
October 4, 2016
Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception?
Umberto Capitanio, Alessandro Larcher, Paolo Dell'Oglio, et al.
European Urology
|
October 15, 2022
Long-distance Robot-assisted Teleoperation: Every Millisecond Counts
Alessandro Larcher, Federico Belladelli, Umberto Capitanio, et al.
European Urology
|
March 14, 2022
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. 2022;81:576-85
Francesco Montorsi, Umberto Capitanio, Giuseppe Rosiello, et al.
Page
of 34
Search research articles
Search
Showing results (11-20 of 334) with videos related to
Sort By:
Page
of 34
European Urology Oncology
|
April 25, 2019
Re: Ricardo G. Alvim, François Audenet, Emily A. Vertosick, Daniel D. Sjoberg, Karim A. Touijer. Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL, and PADUA Systems. Eur Urol Oncol 2018;1:428-34: Nephrometry Score: Quantifying the Complexity of the Tumor or Struggling with the Complexity of the Score?
Fabio Muttin, Umberto Capitanio, Francesco Montorsi, et al.
European Urology Open Science
|
January 6, 2022
Cytoreductive Nephrectomy in 2021: Obsolete but Necessary
Umberto Capitanio, Andrea Necchi, Francesco Montorsi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2016
The Authors Respond
Nicola Fossati, Alessandro Larcher, Alberto Briganti, et al.
European Urology
|
March 30, 2016
Oncologic Surveillance for Renal Cell Carcinoma: What Is Still Needed?
Umberto Capitanio, Giorgio Gandaglia, Alessandro Larcher, et al.
The Journal of Urology
|
May 13, 2026
Interpreting Matched Analyses of Partial Versus Radical Nephrectomy for cT2 Tumors: Methodological Caveats and Clinical Implications
Umberto Capitanio, Francesco Cei, Alessandro Larcher, et al.
Urologic Oncology
|
June 1, 2022
Reply to Sebastiano Buti and Giulia Claire Giudice's Letter to the Editor comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: Is AUC close enough to clinical practice? Urol Oncol. 2022 Apr 14:S1078-1439(22)00066-7. doi: 10.1016/j.urolonc.2022.02.015
Giuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
February 10, 2018
You Can Trust a Crystal Ball About as Far as You Can Throw It
Umberto Capitanio, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
October 4, 2016
Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception?
Umberto Capitanio, Alessandro Larcher, Paolo Dell'Oglio, et al.
European Urology
|
October 15, 2022
Long-distance Robot-assisted Teleoperation: Every Millisecond Counts
Alessandro Larcher, Federico Belladelli, Umberto Capitanio, et al.
European Urology
|
March 14, 2022
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. 2022;81:576-85
Francesco Montorsi, Umberto Capitanio, Giuseppe Rosiello, et al.
Page
of 34